UK Lung Cancer RCT Pilot Screening Trial: Baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening

Thorax

Volumn 71, Issue 2, 2016, Pages 161-170

  Field, J K ^a   Duffy, S W ^b   Baldwin, D R ^c   Whynes, D K ^d   Devaraj, A ^e   Brain, K E ^f   Eisen, T ^g   Gosney, J ^h   Green, B A ^a   Holemans, J A ⁱ   Kavanagh, T ^j   Kerr, K M ^k   Ledson, M ⁱ   Lifford, K J ^f   McRonald, F E ^a   Nair, A ^l   Page, R D ⁱ   Parmar, M K B ^m   Rassl, D M ⁿ   Rintoul, R C ⁿ   Screaton, N J ⁿ   Wald, N J ^b   Weller, D ^o   Williamson, P R ^a   Yadegarfar, G ^a   Hansell, D M ^e   more..

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^f CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

ⁱ LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^j Lung Cancer Patient Advocate   (United Kingdom)

^k ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^l GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^m MEDICAL RESEARCH COUNCIL   (United Kingdom)

ⁿ PAPWORTH HOSPITAL   (United Kingdom)

^o UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH ECONOMICS; HIGH RISK PATIENT; HUMAN; LUNG CANCER; LUNG NODULE; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TUMOR VOLUME; UNITED KINGDOM; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; X-RAY COMPUTED TOMOGRAPHY;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PILOT PROJECTS; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SURVEYS AND QUESTIONNAIRES; TOMOGRAPHY, X-RAY COMPUTED; UNITED KINGDOM;

EID: 84958952298     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-207140     Document Type: Article

References (20)

1. Aberle DR, Adams AM, Berg CD, et al., National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 2013;159:411-20.
3. Field JK, Smith RA, Aberle DR, et al. International Association for the Study of Lung Cancer computed tomography screening workshop 2011 report. J Thorac Oncol 2012;7:10-19.
4. Field JK, Hansell DM, Duffy SW, et al. CT screening for lung cancer: countdown to implementation. Lancet Oncol 2013;14:e591-600.
5. Baldwin DR, Duffy SW, Wald NJ, et al. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 2011;66:308-13.
6. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74.
7. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6.
8. Raji OY, Duffy SW, Agbaje OF, et al. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med 2012;157:242-50.
9. Brenner DR, Boffetta P, Duell EJ, et al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am J Epidemiol 2012;176:573-85.
10. McRonald FE, Yadegarfar G, Baldwin DR, et al. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) 2014;7:362-71.
11. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.
12. Horeweg N, van der Aalst CM, Thunnissen E, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013;187:848-54.
13. Ali N, Lifford K, Carter B, et al. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open 2015;5:e008254.
14. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-41.
15. Horeweg N, van der Aalst CM, Vliegenthart R, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42:1659-67.
16. Black WC, Gareen IF, Soneji SS, et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 2014;371:1793-802.
17. Field JK, van Klaveren R, Pedersen JH, et al. European randomized lung cancer screening trials: post NLST. J Surg Oncol 2013;108:280-6.
18. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-54.
19. Field JK, Oudkerk M, Pedersen JH, et al. Prospects for population screening and diagnosis of lung cancer. Lancet 2013;382:732-41.
20. Field JK. Perspective: The screening imperative. Nature 2014;513:S7.